Title: Perioperative Blood Transfusion in Patients Undergoing Cancer Surgery- A Clinical Study

Authors: Shipra Singh, Dr V N Vaid, Dr Pankaj Mishra, Dr K G Rao

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i10.113

Abstract

Background: Allogenic blood transfusion is associated with several potential complications, especially in patients with cancer. The hazards of allogenic blood transfusion include transmission of infection and immunological reactions. The aim of the study was to identify the rates of perioperative blood transfusion and over transfusion in patients undergoing cancer surgery.

Materials & Methods: This study was conducted in the department of Anesthesiology in year 2015. It included 1236 patients of both genders. Information such as intra-operative blood loss and fluid therapy, blood and blood products transfused (if any) and any intraoperative investigations were recorded.

Results: Out of 1236 patients, males were 616 and females were 620. The difference was non- significant (P-1). Mean age of males were 62.2 years and females 58.7 years. Mean weight was 68.6 kg and 66.4 kg respectively. ASA status was I (males- 32%, females- 30%), II (males-18%, females- 16%), III (males- 2%, females- 2%). Hemoglobin Hb was <8 (males- 2.5%, females- 1.5%), 8-10 (males- 6%, females- 4%), >10 (males- 42%, females- 44%).  Need of blood transfusion was divided into low (males- 30%, females- 34%), moderate (males- 14%, females- 16%) and high (males- 4%, females- 2%). The difference was non- significant (P> 0.05).

1 unit blood was used in 680 patients, with 65% appropriate rate and 35% over transfusion. 2 units blood was used in 412 patients, with 52% appropriate rate and 48% over transfusion. >2 units blood was used in 144 patients, with 44% appropriate rate and 56% over transfusion.

Conclusion: Blood transfusion is required in most of cancer patient surgeries. There is requirement of strict watch on amount of blood to be transfused and over transfusion.

Keywords: Blood transfusion, Infection, Immunological reactions.

References

  1. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine. First of two parts--blood transfusion. N Engl J Med. 1999; 340: 438-47.
  2. Dellinger EP, Anaya DA. Infectious and immunologic consequences of blood transfusion. Crit Care. 2004; 8:18-23.
  3. Amato A, Pescatori M. Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev. 2006; 1: 14-20.
  4. Choy YC, Lim WL, Ng SH. Audit of perioperative blood transfusion. Med J Malaysia. 2007; 62: 299-302.
  5. Spencer J, Thomas SR, Yardy G, Mukundan C, Barrington R. Are we overusing blood transfusing after elective joint replacement? A simple method to reduce the use of a scarce resource. Ann R Coll Surg Engl. 2005; 87: 28-30.
  6. Niraj G, Puri GD, Arun D, Chakravarty V, Aveek J, Chari P. Assessment of intraoperative blood transfusion practice during elective non-cardiac surgery in an Indian tertiary care hospital. Br J Anaesth. 2003; 91: 586-9.
  7. Mallett SV, Peachey TD, Sanehi O, Hazlehurst G, Mehta A. Reducing red blood cell transfusion in elective surgical patients: The role of audit and practice guidelines. Anaesthesia 2000; 55:1013-9.
  8. Sudhindran S. Perioperative blood transfusion: A plea for guidelines. Ann R Coll Surg Engl. 1997; 79: 299-302.
  9. Hallissey MT, Crowson MC, Kiff RS, Kingston RD, Fielding JW. Blood transfusion: An overused resource in colorectal cancer surgery. Ann R Coll Surg Engl. 1992; 74:59-62.

Corresponding Author

Dr V N Vaid

Associate Professor Anaesthesia, Mayo Institute of Medical Sciences Barabanki, Lucknow, U.P, India

SW101, Golf Link Apartments 98-Park Road, Lucknow-226001